Home › Calculator › GSK Dividend Calculator 2026
GSK Dividend DRIP Calculator 2026
3.38% YieldHealthcareGSK plc · NYSE
Price: $53.32 · Annual div: $1.80/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When GSK pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your GSK snowball 📈
$10,000 in GSK → $10.81M in 10 years · $253.37/month
About GSK plc (GSK) — Dividend Analysis 2026
GSK plc, a global pharmaceutical entity founded in 1715 and headquartered in Brentford, United Kingdom, dedicates its efforts to the research, development, and manufacturing of a wide array of medical solutions. Until May 2022, the company was known as GlaxoSmithKline plc. Its primary objective is to prevent and treat illnesses by producing both vaccines and a comprehensive range of specialty and general medicines for markets across the United Kingdom, the United States, and internationally. The company's operations are organized into two key divisions: Commercial Operations and Total R&D. Its extensive vaccine portfolio includes immunizations against shingles, meningitis, respiratory syncytial virus (RSV), seasonal and pandemic influenza, and polio. Beyond preventative care, GSK provides diverse therapeutic products covering critical areas such as HIV, oncology, respiratory and immunology conditions, and other specialized medical fields. This also encompasses inhaled treatments for chronic respiratory ailments like asthma and chronic obstructive pulmonary disease (COPD), along with antibiotics for various infections. Innovation at GSK is frequently driven by strategic partnerships. Notable collaborations include an agreement with CureVac to advance mRNA-based influenza vaccines, and alliances with Wave Life Sciences and Elsie Biotechnologies focused on developing oligonucleotide platforms. Furthermore, GSK has established two distinct strategic collaborations with Relation to progress therapeutics for fibrotic diseases and osteoarthritis. The company is also engaged in a multi-target strategic alliance aimed at developing pioneering treatments for individuals suffering from Parkinson's disease, and a partnership with Flagship Pioneering to identify novel medicines and vaccines.
Compare GSK with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full GSK DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GSK position with:
🌍 GSK Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GSK.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 3.38% | 0.58% | $338 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.87% | 0.07% | $287 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.70% | -0.10% | $270 / yr |
| 🇬🇧 UK ISA | 0% | 3.38% | 0.58% | $338 / yr |
| 🇬🇧 UK Taxable | 8.75% | 3.08% | 0.28% | $308 / yr |
| 🇨🇦 TFSA | 0% | 3.38% | 0.58% | $338 / yr |
| 🇨🇦 CA Taxable | 25% | 2.54% | -0.26% | $254 / yr |
| 🇦🇺 Super (pension) | 15% | 2.87% | 0.07% | $287 / yr |
| 🇦🇺 AU Taxable | 30% | 2.37% | -0.43% | $237 / yr |
| 🇩🇪 DE Taxable | 26.375% | 2.49% | -0.31% | $249 / yr |
| 🇫🇷 FR Taxable | 30% | 2.37% | -0.43% | $237 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GSK Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $1.80/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GSK Dividend Payment Schedule
GSK pays quarterly — 4 times per year. Next ex-div: TBD.
📊 GSK vs Healthcare Benchmarks
How GSK compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GSK sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GSK Insider Activity
No recent SEC filings reported in the last 90 days.Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where GSK earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GSK dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
GSK plc (GSK) is currently trading at $53.32, 9% below its 52-week high. The current dividend yield is 3.38% based on an annual payout of $1.80 per share.
GSK (GSK plc) — 3.38% Dividend Yield Analysis
GSK plc (GSK) is a healthcare stock currently trading at $53.32 with a dividend yield of 3.38%. The company pays an annual dividend of $1.80 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, GSK has grown its dividend at a compound annual rate of 23.9%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.